EMERGENCE OF MULTIDRUG RESISTANT BACTERIA AMONG PATIENTS WITH RESPIRATORY TRACT INFECTIONS
DOI:
https://doi.org/10.36103/ijas.v54i6.1860Keywords:
Pseudomonas aeruginosa, plasmid DNA, transformation, β-lactam resistance, horizontal gene transfer, respiratory infections.Abstract
In this study, 25 Pseudomonas aeruginosa isolates were diagnosed in 160 clinical samples collected from patients attending the Tuberculosis Institute/ Medical city and Al-Muhmodia Public Hospital, in addition to a number of private laboratories in Baghdad during the period from September 2020 to February 2021. The bacterial isolates from clinical samples were biochemically diagnosed by API® 20E system then further identified by VITEK 2 system. P. aeruginosa represented the most prevalent bacteria in lower respiratory tract specimens. These isolates showed moderate to high susceptibility towards 11 antimicrobial agents tested in this study except that of ceftazidime and ceftriaxone. Extra-chromosomal resistance of the top three of the most resistant P. aeruginosa isolates were subjected for molecular investigation. Bacterial transformation of E. coli S1 cells with plasmid DNA extracted from the selected P. aeruginosa isolates exhibited increased resistance to ceftazidime and penicillin G. The data clearly suggest that the plasmid DNA content is implicated in enhancement of P. aeruginosa resistance through horizontal transfer of extra- chromosomal beta lactam resistance associated genes.
References
Arai, H. 2011. Regulation and function of versatile aerobic and anaerobic respiratory metabolism in Pseudomonas aeruginosa. Front Microbiol 2, 103.
Berube, B. J. S. M., Rangel and A. R. Hauser. 2016. Pseudomonas aeruginosa: breaking down barriers. Curr Genet 62, 109-113.
Borman, A. M. J., Muller; J., Walsh- Quantick; A., Szekely; Z., Patterson;M. D., Palmer and E. M. Johnson. 2020. MIC distributions for amphotericin B, fluconazole, itraconazole,voriconazole, flucytosine and anidulafungin and 35 uncommon pathogenic yeast species from the UK determined using the CLSI broth microdilution method. Journal of Antimicrobial Chemotherapy, 75(5), 1194-1205.
Carattoli, A.; E., Zankari; A., García- Fernández; M., Voldby Larsen; O., Lund; L., Villa and H. Hasman. 2014. In silico detection and typing of plasmids using plasmid finder and plasmid multilocus sequence typing. Antimicrobial agents and chemotherapy, 58(7), 3895-3903.
Carmeli, Y., J., Armstrong; P. J., Laud; P., Newell G.,; Stone; A., Wardman and L. B. Gasink. 2016. Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections orcomplicatedintra- abdominal infections (REPRISE): a randomized pathogen-directed, phase 3 study. The Lancet Infectious Diseases 16, 661-673.
Carroll, I. M. T., Ringel-Kulka; J. P., Siddle; T. R., Klaenhammer and Y. Ringel. 2012. Characterization of the fecal microbiota using high- throughput sequencing reveals a stable microbial community during storage. PloS one, 7(10), e46953.
Chun, L. Y. L., Dolle-Molle; C., Bethel; R. C., Dimitroyannis; B. L., Williams; S. A., Schechet and D. Skondra. 2019. Rapid pathogen identification and antimicrobial susceptibility testing in in vitro endophthalmitis with matrix assisted laser desorption-ionization Time-of- Flight Mass Spectrometry and VITEK 2 without prior culture. Plos one, 14(12), e0227071.
Crousilles, A.; E., Maunders; S., Bartlett; C., Fan; E. F., Ukor; Y., Abdelhamid and M., Welch.2015. Which microbial factors really are important in Pseudomonas aeruginosa infectios?. Future microbiology, 10(11), 1825-1836.
Deshpande, R. and C. Zou, 2020 Pseudomonas aeruginosa Induced cell death in acute lung injury and acute respiratory distress syndrome. Int J Mol Sci 21.
Don, J.; R. Noel and T. James. 2005. Bergey’s Manual-of Systematic Bacteriology. (2PndP ed.). contributions from 339 colleagues.
Dubnau, D. and M. Blokesch. 2019. Mechanisms of DNA uptake by naturally competent bacteria. Annu Rev Genet 53, 217-237.
El Chakhtoura, N. G. E., Saade; A., Iovleva; M., Yasmin; B., Wilson; F., Perez and R. A. Bonomo.2018. Therapies for multidrug resistant and extensively drug-resistant non- fermenting gram-negative bacteria causing nosocomial infections: a perilous journey toward 'molecularly targeted' therapy. Expert Rev Anti Infect Ther 16, 89-110.
Eyns, H. D., Pierard; E., De Wachter; L., Eeckhout; P., Vaes and A. Malfroot. 2018. Respiratory bacterial culture sampling in expectorating and non-expectorating patients with cystic fibrosis. Front Pediatr 6, 403
Fadhel Abb, S., A. S. K., Al-Khafaji and H. M. Radif. 2018. Investigation of plasmid-associated fluoroquinolone resistance in nosocomial Pseudomonas aeruginosa isolated from infected burn wounds. Journal of Biological Sciences 18, 514-519.
Faqri, A. A. N. H., Hayder and A. J. Hashim. 2019. Lab-scale production of rhamnolipid by a3 and study its synergistic effect with certain antibiotics against some pathogenic bacteria. Iraqi Journal of Agricultural Science, 50(4), 1290- 1301. https://doi.org/10.36103/ijas.v50i5.794
Galetti, R., L. N., Andrade; M., Chandler; M., Varani Ade and A. L. Darini.2016. New small plasmid harboring blaKPC-2 in Pseudomonas aeruginosa. antimicrob agents chemother 60, 3211-3214.
Gupta, R. and M. Schuster. 2012. Quorum sensing modulates colony morphology through alkyl quinolones in Pseudomonas aeruginosa. BMC microbiology, 12(1), 1-12.
Higgins, N. P. and A. V. Vologodskii. 2015. Topological behavior of plasmid DNA. Microbiol Spectr 3.
Hoiby, N., O., Ciofu and T. Bjarnsholt. 2010. Pseudomonas aeruginosa biofilms in cystic fibrosis. Future microbiology, 5(11), 1663- 1674.
Ibrahim, A. H. 2022. Link between some virulence factors genes and antibacterial resistance of Pseudomonas aeruginosa. Iraqi Journal of Agricultural Sciences, 53(5), 985-993. https://doi.org/10.36103/ijas.v53i5.1612
Hussein, N. N. and A. H. Muslim.2019. Detection of the antibacterial activity of AgNPs biosynthesized by Pseudomonas aeruginosa. Iraqi Journal of Agricultural Science, 50(2), 617-625. https://doi.org/10.36103/ijas.v2i50.661
Li, H. M. A., Toleman; P. M., Bennett; R. N., Jones and T. R. Walsh.2008. Complete sequence of p07-406, a 24,179-base-pair plasmid harboring the blaVIM-7 metallo- beta-lactamase gene in a Pseudomonas aeruginosa isolate from the United States. Antimicrob Agents Chemother 52, 3099-3105.
Manjunath, S. V. R. S., Baghel and M. Kumar 2020. Antagonistic and synergistic analysis of antibiotic adsorption on Prosopis juliflora activated carbon in multicomponent systems. Chemical Engineering Journal, 381, 122713.
Nafee, S. K. 2012. Isolation And Identification of Clinical Pseudomonas aeruginosa Producing Exotoxin A And Studying Its Toxic Effect In Mice (Doctoral dissertation, thesis. MV Sc. College of Science/Baghdad Univ. Master of Science in Biotechnology).
Nolan, L. M.; L., Turnbull; M., Katrib; S. R., Osvath; D., Losa; J. J., Lazenby and C. B. Whitchurch. 2020. Pseudomonas aeruginosa is capable of natural transformation in biofilms. Microbiology (Reading) 166, 995- 1003.
O'Neill, J. 2016. Tackling drug- resistant infections globally: final report and recommendations.
Qasim, D. A. 2019. Molecular detection of Pseudomonas aeruginosa isolated from minced meat and studies the pyocyanin effectiveness on pathogenic bacteria. Iraqi Journal of Agricultural Sciences, 50(4):1199-1207. https://doi.org/10.36103/ijas.v50i4.764
Qureshi, H.; A., Sharafkhaneh and N.Hanania. 2014. Chronic obstructive pulmonary disease exacerbations: latest evidence and clinical implications. Therapeutic advances in chronic disease, 5(5), 212-227.
Siddalingappa, C. M.; L., Kalpana; S., Puli; T. K., Vasudha and A. Acharya. 2013. Sensitivity pattern of bacteria causing respiratory tract infections in a tertiary care centre. International Journal of Basic and Clinical Pharmacology, 2(5), 590- 595.
Thomas, M. and P. A. Bomar. 2020. Upper respiratory tract infection. StatPearls.
Tawfiq, S. M. 2018. Bacteriologigal and genetic study of Pseudomonas aeruginosa isolates. Iraqi Journal of Agricultural Sciences, 49(1): 27-35. https://doi.org/10.36103/ijas.v49i1.201
Wang, Y. J., Wang; R., Wang and Y. Cai. 2020. Resistance to ceftazidime- avibactam and underlying mechanisms. J Glob Antimicrob Resist 22, 18-27
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
2.jpg)
2.jpg)
